[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596802":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":43,"centralContacts":47,"locations":54,"responsibleParty":68,"collaborators":52,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":52,"eligibilityCriteria":77,"healthyVolunteers":78,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":52,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":52,"overallStatus":56,"whyStopped":52,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Maternal and Child Health Hospital of Hubei Province","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Remimazolam group: Remimazolam is administered intravenously at a dose of 0.3 mg\u002Fkg","EXPERIMENTAL","Remimazolam is administered intravenously at a dose of 0.3 mg\u002Fkg",[13],"Drug: remimazolam group",{"label":15,"type":16,"description":17,"interventionNames":18},"dexmedetomidine group: dexmedetomidine is administered intravenously at a dose of 1 μg\u002Fkg","ACTIVE_COMPARATOR","dexmedetomidine is administered intravenously at a dose of 1 μg\u002Fkg",[19],"Drug: dexmedetomidine group",{"label":21,"type":16,"description":22,"interventionNames":23},"esketamine group: esketamine is administered intravenously at a dose of 0.5 mg\u002Fkg","esketamine is administered intravenously at a dose of 0.5 mg\u002Fkg",[24],"Drug: esketamine group",[26,33,38],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","remimazolam group","remimazolam is administered intravenously at a dose of 0.3 mg\u002Fkg",[9],[32],"remimazolam",{"type":27,"name":34,"description":17,"armGroupLabels":35,"otherNames":36},"dexmedetomidine group",[15],[37],"dexmedetomidine",{"type":27,"name":39,"description":22,"armGroupLabels":40,"otherNames":41},"esketamine group",[21],[42],"esketamine",[44],{"name":45,"affiliation":5,"role":46},"Na Li NaLi, MD","PRINCIPAL_INVESTIGATOR",[48],{"name":49,"role":50,"phone":51,"phoneExt":52,"email":53},"NaLi, MD","CONTACT","+862763490107",null,"lina@hbfy.com",[55],{"facility":5,"status":56,"city":57,"state":58,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":52},"RECRUITING","Wuhan","Hubei","430000","China","CN",{"type":63,"coordinates":64},"Point",[65,66],114.26667,30.58333,{"lat":66,"lon":65},{"type":46,"investigatorFullName":69,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":52,"oldOrganization":52},"Li Na","Deputy Chief Physician","100596802","application-of-remimazolam-dexmedetomidine-and-esketamine-in-pediatric-preoperative-sedation-100596802",false,"NCT07050212","Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation","A Comparative Study of the Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation","Inclusion Criteria:\n\n1. Children aged 2 to 5 years old\n2. the American Society of Anesthesiologists (ASA) physical status of Class I\n3. scheduled for adenotonsillectomy under general anesthesia, will be included.\n\nExclusion Criteria:\n\n1. Abnormal lung function and respiratory system function\n2. airway obstruction or deformity, history of mental illness\n3. electrocardiogram indicating bradycardia\n4. history of cardiac disease",true,"ALL","2 Years","5 Years",{"count":83,"type":84},150,"ESTIMATED","INTERVENTIONAL",[87],"NA","By comparing the application effects of three drugs in pediatric preoperative sedation, this study explores the optimal medication regimen, aiming to provide safer, more effective, and more personalized medication options for pediatric preoperative sedation. Additionally, this research will also focus on the impact of these three drugs on postoperative agitation in children, offering valuable references for the overall management of pediatric surgical anesthesia.",[90,91,92],"Remimazolam","Dexmedetomidine","Esketamine","2025-07-04",{"date":95,"type":96},"2025-07-10","ACTUAL",{"date":98,"type":96},"2025-04-01",{"date":100,"type":84},"2026-03-01",{"name":5,"class":6},1]